explore -WSS

explore

author：entertainment 2025-09-29 00:39:26 - browse：62

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Mike Pence clashes with Tucker Carlson in Iowa

WSS

Woman gored by Bison at Yellowstone

Intellia plays down concerns on accidental germline transmission

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Can CDC director Mandy Cohen drive consensus in Washington?

Does aspartame cause cancer? What new WHO guidance says

Federal judge rules Oregon’s tough new gun law is constitutional

leisure time

explore

knowledge

Medical records are filled with copy

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Cancer drug shortages should be causing more outrage

As obesity drug market grows, telehealth companies court payers

Trump demands the U.S. pay no more for drugs than other countries … again

Who gets to use the title 'doctor'?

Activists slam private health insurers over coverage restrictions

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Alkermes shareholders re

Listen: Vivek Ramaswamy's star turn & leaky drug data

focus

Health officials lay out plans to cope with respiratory virus season

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

California store owner shot dead in dispute over displaying Pride flag: Police

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Kellogg’s is going to war over Mexico’s nutrition label rules

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

explore

focus

hotspot

focus